Physician profile
Lynne E Benjamin
NPI 1134528946
$557.80
in general payments reported to CMS, 2019-2025
13 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.61 · 2022: $79.12 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $457.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $149.72 | 2025 | Rezdiffra |
| Abbvie INC. | $79.12 | 2022 | |
| Pfizer INC. | $66.30 | 2025 | |
| Sumitomo Pharma America, INC. | $56.19 | 2025 | Gemtesa |
| Glaxosmithkline, LLC. | $40.47 | 2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $26.41 | 2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $23.00 | 2025 | Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $22.07 | 2025 | Airsupra |
| Lundbeck LLC | $21.96 | 2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $21.61 | 2021 | |
| Exact Sciences Corporation | $19.91 | 2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $15.85 | 2025 | Auvelity |
| Kowa Pharmaceuticals America, INC. | $15.19 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynne Benjamin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.